Interactions Between Botulinum Neurotoxins and Synaptic Vesicle Proteins

Botulinum Toxin: Therapeutic Clinical Practice and Science

Volumn , Issue , 2009, Pages 41-54

  Brunger, Axel T ^a   Jin, Rongsheng ^b   Breidenbach, Mark A ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882869445     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4928-9.00004-4     Document Type: Chapter

References (112)

1. Hatheway CL Toxigenic clostridia. Clin Microbiol Rev 1990, 3:66-98.
2. Montecucco C, Schiavo G Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 1995, 28:423-472.
3. Erbguth FJ Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 2004, 19(Suppl 8):S2-S6.
4. Kao I, Drachman DB, Price DL Botulinum toxin: mechanism of presynaptic blockade. Science 1976, 193:1256-1258.
5. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993, 365:160-163.
6. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de, Laureto P, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992, 359:832-835.
7. Sobel J, Tucker N, Sulka A, McLaughlin J, Maslanka S Foodborne botulism in the United States, 1990-2000. Emerg Infect Dis 2004, 10:1606-1611.
8. Kessler KR, Benecke R Botulinum toxin: from poison to remedy. Neurotoxicology 1997, 18:761-770.
9. Gui D, Rossi S, Runfola M, Magalini SC Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther 2003, 18:1-16.
10. Charles PD Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses. Am J Health Syst Pharm 2004, 61(Suppl 6):S11-S23.
11. Munchau A, Bhatia KP Uses of botulinum toxin injection in medicine today. BMJ 2000, 320:161-165.
12. Niemann H, Blasi J, Jahn R Clostridial neurotoxins: new tools for dissecting exocytosis. Trends Cell Biol 1994, 179-185.
13. Helting TB, Parschat S, Engelhardt H Structure of tetanus toxin. Demonstration and separation of a specific enzyme converting intracellular tetanus toxin to the extracellular form. J Biol Chem 1979, 254:10728-10733.
14. Weller U, Dauzenroth ME, Meyer ZU, Heringdorf D, Habermann E Chains and fragments of tetanus toxin. Separation, reassociation and pharmacological properties. Eur J Biochem 1989, 182:649-656.
15. Schiavo G, Papini E, Genna G, Montecucco C An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin. Infect Immun 1990, 58:4136-4141.
16. Turton K, Chaddock JA, Acharya KR Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 2002, 27:552-558.
17. Fujinaga Y, Inoue K, Watarai S, Sakaguchi Y, Arimitsu H, Lee JC, et al. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 2004, 150(Pt 5):1529-1538.
18. Binz T, Kurazono H, Wille M, Frevert J, Wernars K, Niemann H The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J Biol Chem 1990, 265:9153-9158.
19. Lacy DB, Stevens RC Sequence homology and structural analysis of the clostridial neurotoxins. J Mol Biol 1999, 291:1091-1104.
20. Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 1998, 5:898-902.
21. Swaminathan S, Eswaramoorthy S Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 2000, 7:693-699.
22. Schiavo G, Matteoli M, Montecucco C Neurotoxins affecting neuroexocytosis. Physiol Rev 2000, 80:717-766.
23. Simpson LL Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004, 44:167-193.
24. Kurazono H, Mochida S, Binz T, Eisel U, Quanz M, Grebenstein O, et al. Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A. J Biol Chem 1992, 267:14721-14729.
25. Blasi J, Chapman ER, Yamasaki S, Binz T, Niemann H, Jahn R Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. Embo J 1993, 12:4821-4828.
26. Schiavo G, Shone CC, Bennett MK, Scheller RH, Montecucco C Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J Biol Chem 1995, 270:10566-10570.
27. Foran P, Lawrence GW, Shone CC, Foster KA, Dolly JO Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 1996, 35:2630-2636.
28. Vaidyanathan VV, Yoshino K, Jahnz M, Dorries C, Bade S, Nauenburg S, et al. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J Neurochem 1999, 72:327-337.
29. Williamson LC, Halpern JL, Montecucco C, Brown JE, Neale EA Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J Biol Chem 1996, 271:7694-7699.
30. Van der Kloot W Loading and recycling of synaptic vesicles in the Torpedo electric organ and the vertebrate neuromuscular junction. Prog Neurobiol 2003, 71:269-303.
31. Aravanis AM, Pyle JL, Tsien RW Single synaptic vesicles fusing transiently and successively without loss of identity. Nature 2003, 423:643-647.
32. Gandhi SP, Stevens CF Three modes of synaptic vesicular recycling revealed by single-vesicle imaging. Nature 2003, 423:607-613.
33. Sudhof TC The synaptic vesicle cycle. Annu Rev Neurosci 2004, 27:509-547.
34. Harbury PA Springs and zippers: coiled coils in SNARE-mediated membrane fusion. Structure 1998, 6:1487-1491.
35. Schuette CG, Hatsuzawa K, Margittai M, Stein A, Riedel D, Kuster P, et al. Determinants of liposome fusion mediated by synaptic SNARE proteins. Proc Natl Acad Sci U S A 2004, 101:2858-2863.
36. Sollner TH Intracellular and viral membrane fusion: a uniting mechanism. Curr Opin Cell Biol 2004, 16:429-435.
37. Sollner T SNAREs and targeted membrane fusion. FEBS Lett 1995, 369:80-83.
38. Veit M, Sollner TH, Rothman JE Multiple palmitoylation of synaptotagmin and the t-SNARE SNAP-25. FEBS Lett 1996, 385:119-123.
39. Sutton RB, Fasshauer D, Jahn R, Brunger AT Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 1998, 395:347-353.
40. Otto H, Hanson PI, Jahn R Assembly and disassembly of a ternary complex of synaptobrevin, syntaxin, and SNAP-25 in the membrane of synaptic vesicles. Proc Natl Acad Sci U S A 1997, 94:6197-6201.
41. Hanson PI, Roth R, Morisaki H, Jahn R, Heuser JE Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy. Cell 1997, 90:523-535.
42. Lin RC, Scheller RH Structural organization of the synaptic exocytosis core complex. Neuron 1997, 19:1087-1094.
43. Matos MF, Mukherjee K, Chen X, Rizo J, Sudhof TC Evidence for SNARE zippering during Ca2+-triggered exocytosis in PC12 cells. Neuropharmacology 2003, 45:777-786.
44. Fasshauer D, Bruns D, Shen B, Jahn R, Brunger AT A structural change occurs upon binding of syntaxin to SNAP-25. J Biol Chem 1997, 272:4582-4590.
45. Hazzard J, Sudhof TC, Rizo J NMR analysis of the structure of synaptobrevin and of its interaction with syntaxin. J Biomol NMR 1999, 14:203-207.
46. Fiebig KM, Rice LM, Pollock E, Brunger AT Folding intermediates of SNARE complex assembly. Nat Struct Biol 1999, 6:117-123.
47. Ossig R, Schmitt HD, de Groot B, Riedel D, Keranen S, Ronne H, et al. Exocytosis requires asymmetry in the central layer of the SNARE complex. EMBO J 2000, 19:6000-6010.
48. Fasshauer D, Eliason WK, Brunger AT, Jahn R Identification of a minimal core of the synaptic SNARE complex sufficient for reversible assembly and disassembly. Biochemistry 1998, 37:10354-10362.
49. Ernst JA, Brunger AT High resolution structure, stability, and synaptotagmin binding of a truncated neuronal SNARE complex. J Biol Chem 2003, 278:8630-8636.
50. Kubista H, Edelbauer H, Boehm S Evidence for structural and functional diversity among SDS-resistant SNARE complexes in neuroendocrine cells. J Cell Sci 2004, 117(Pt 6):955-966.
51. Fasshauer D Structural insights into the SNARE mechanism. Biochim Biophys Acta 2003, 1641:87-97.
52. Chen YA, Scheller RH SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol 2001, 2:98-106.
53. Sollner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, et al. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993, 362:318-324.
54. Fernandez-Chacon R, Shin OH, Konigstorfer A, Matos MF, Meyer AC, Garcia J, et al. Structure/function analysis of Ca2+ binding to the C2A domain of synaptotagmin 1. J Neurosci 2002, 22:8438-8446.
55. Fernandez-Chacon R, Konigstorfer A, Gerber SH, Garcia J, Matos MF, Stevens CF, et al. Synaptotagmin I functions as a calcium regulator of release probability. Nature 2001, 410:41-49.
56. Misura KM, Scheller RH, Weis WI Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex. Nature 2000, 404:355-362.
57. Dulubova I, Khvotchev M, Liu S, Huryeva I, Sudhof TC, Rizo J Munc18-1 binds directly to the neuronal SNARE complex. Proc Natl Acad Sci U S A 2007, 104:2697-2702.
58. Tang J, Maximov A, Shin OH, Dai H, Rizo J, Sudhof TC A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell 2006, 126:1175-1187.
59. Basu J, Shen N, Dulubova I, Lu J, Guan R, Guryev O, et al. A minimal domain responsible for Munc13 activity. Nat Struct Mol Biol 2005, 12:1017-1018.
60. Rizo J, Chen X, Arac D Unraveling the mechanisms of synaptotagmin and SNARE function in neurotransmitter release. Trends Cell Biol 2006, 16:339-350.
61. Schiavo G, Santucci A, Dasgupta BR, Mehta PP, Jontes J, Benfenati F, et al. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 1993, 335:99-103.
62. Yamasaki S, Binz T, Hayashi T, Szabo E, Yamasaki N, Eklund M, et al. Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem Biophys Res Commun 1994, 200:829-835.
63. Oost T, Sukonpan C, Brewer M, Goodnough M, Tepp W, Johnson EA, et al. Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease. Biopolymers 2003, 71:602-619.
64. Agarwal R, Eswaramoorthy S, Kumaran D, Binz T, Swaminathan S Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212->Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway. Biochemistry 2004, 43:6637-6644.
65. Breidenbach MA, Brunger AT 2.3 A crystal structure of tetanus neurotoxin light chain. Biochemistry 2005, 44:7450-7477.
66. Rao KN, Kumaran D, Binz T, Swaminathan S Structural analysis of the catalytic domain of tetanus neurotoxin. Toxicon 2005, 45:929-939.
67. Schmidt JJ, Bostian KA Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin. J Protein Chem 1997, 16:19-26.
68. Yamasaki S, Baumeister A, Binz T, Blasi J, Link E, Cornille F, et al. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J Biol Chem 1994, 269:12764-12772.
69. Foran P, Shone CC, Dolly JO Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry 1994, 33:15365-15374.
70. Cornille F, Martin L, Lenoir C, Cussac D, Roques BP, Fournie-Zaluski MC Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin light chain. J Biol Chem 1997, 272:3459-3464.
71. Schmidt JJ, Bostian KA Proteolysis of synthetic peptides by type A botulinum neurotoxin. J Protein Chem 1995, 14:703-708.
72. Rossetto O, Schiavo G, Montecucco C, Poulain B, Deloye F, Lozzi L, et al. SNARE motif and neurotoxins. Nature 1994, 372:415-416.
73. Pellizzari R, Rossetto O, Lozzi L, Giovedi S, Johnson E, Shone CC, et al. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins. J Biol Chem 1996, 271:20353-20358.
74. Breidenbach MA, Brunger AT Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 2004, 432:925-929.
75. Segelke B, Knapp M, Kadkhodayan S, Balhorn R, Rupp B Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity. Proc Nat Acad Sci U S A 2004, 101:6888-6893.
76. Jin R, Sikorra S, Stegmann CM, Pich A, Binz T, Brunger AT Structural and biochemical studies of botulinum neurotoxin serotype c1 light chain protease: implications for dual substrate specificity. Biochemistry 2007, 46:10685-10693.
77. Arndt JW, Chai Q, Christian T, Stevens RC Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity. Biochemistry 2006, 45:3255-3262.
78. Agarwal R, Binz T, Swaminathan S Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design. Biochemistry 2005, 44:11758-11765.
79. Arndt JW, Yu W, Bi F, Stevens RC Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition. Biochemistry 2005, 44:9574-9580.
80. Binz T, Blasi J, Yamasaki S, Baumeister A, Link E, Sudhof TC, et al. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 1994, 269:1617-1620.
81. Chen S, Barbieri JT Unique substrate recognition by botulinum neurotoxins serotypes A and E. J Biol Chem 2006, 281:10906-10911.
82. Hanson MA, Stevens RC Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution. Nat Struct Biol 2000, 7:687-692.
83. Rupp B, Segelke B Questions about the structure of the botulinum neurotoxin B light chain in complex with a target peptide. Nat Struct Biol 2001, 8:663-664.
84. Washbourne P, Pellizzari R, Baldini G, Wilson MC, Montecucco C Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis. FEBS Lett 1997, 418:1-5.
85. Brunger AT Structure and function of SNARE and SNARE-interacting proteins. Q Rev Biophys 2006, 38:1-47.
86. Lazarovici P, Yavin E Affinity-purified tetanus neurotoxin interaction with synaptic membranes: properties of a protease-sensitive receptor component. Biochemistry 1986, 25:7047-7054.
87. Pierce EJ, Davison MD, Parton RG, Habig WH, Critchley DR Characterization of tetanus toxin binding to rat brain membranes. Evidence for a high-affinity proteinase-sensitive receptor. Biochem J 1986, 236:845-852.
88. Montecucco C How do tetanus and botulinum neurotoxins bind to neuronal membranes?. Trends Biochem Sci 1986, 11:314-317.
89. Dolly JO Probing the process of transmitter release with botulinum and tetanus neurotoxin. Semin Neurosci 1994, 6:149-158.
90. Eswaramoorthy S, Kumaran D, Swaminathan S Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B. Acta Crystallogr D Biol Crystallogr 2001, 57(Pt 11):1743-1746.
91. Rummel A, Mahrhold S, Bigalke H, Binz T The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol 2004, 51:631-643.
92. Rummel A, Bade S, Alves J, Bigalke H, Binz T Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity. J Mol Biol 2003, 326:835-847.
93. Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol 2003, 162:1293-1303.
94. Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, et al. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006, 312:592-596.
95. Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 2006, 580:2011-2014.
96. Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sato K, et al. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett 1996, 378:253-257.
97. Rummel A, Karnath T, Henke T, Bigalke H, Binz T Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem 2004, 279:30865-30870.
98. Baldwin MR, Barbieri JT Association of botulinum neurotoxin serotypes A and B with synaptic vesicle protein complexes. Biochemistry 2007, 46:3200-3210.
99. Tacket CO, Shandera WX, Mann JM, Hargrett NT, Blake PA Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984, 76:794-798.
100. Pang ZP, Sun J, Rizo J, Maximov A, Sudhof TC Genetic analysis of synaptotagmin 2 in spontaneous and Ca2+-triggered neurotransmitter release. EMBO J 2006, 25:2039-2050.
101. Jin R, Rummel A, Binz T, Brunger AT Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 2006, 444:1092-1095.
102. Chai Q, Arndt JW, Dong M, Tepp WH, Johnson EA, Chapman ER, et al. Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 2006, 444:1096-1100.
103. Rummel A, Eichner T, Weil T, Karnath T, Gutcaits A, Mahrhold S, et al. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc Natl Acad Sci U S A 2007, 104:359-364.
104. Kozaki S, Kamata Y, Watarai S, Nishiki T, Mochida S Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb Pathog 1998, 25:91-99.
105. Bade S, Rummel A, Reisinger C, Karnath T, Ahnert-Hilger G, Bigalke H, et al. Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates. J Neurochem 2004, 91:1461-1472.
106. Hoch DH, Romero-Mira M, Ehrlich BE, Finkelstein A, DasGupta BR, Simpson LL Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc Natl Acad Sci U S A 1985, 82:1692-1696.
107. Koriazova LK, Montal M Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 2003, 10:13-18.
108. Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ Immune recognition of botulinum neurotoxin B: Antibody-binding regions on the heavy chain of the toxin. Mol Immunol 2007, 45:910-924.
109. Montecucco C, Rossetto O, Schiavo G Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol 2004, 12:442-446.
110. Brunger AT, Breidenbach MA, Jin R, Fischer A, Santos JS, Montal M Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain. PLoS Pathog 2007, 3:e113.
111. Humeau Y, Doussau F, Grant NJ, Poulain B How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 2000, 82:427-446.
112. Lalli G, Bohnert S, Deinhardt K, Verastegui C, Schiavo G The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol 2003, 11:431-437.